Overview
PXP Vietnam was the first pure equity-focused Vietnam fund. It was listed in London between 2010 and early 2015 when it merged with an open-ended fund managed by the same manager.
The investment objective of PXP Vietnam Fund was to seek long-term capital appreciation of its assets by investing in a portfolio of the equity securities of Vietnamese companies, whether established with domestic or foreign ownership.
You can access the manager’s website here
News
-
18 Sep 2015 3 min read
Advance Frontiers beats falling benchmark
Last night Advance Frontier Markets published results for the year ended 30 June 2015. Over that period the fund’s net asset value fell by 11.2% and the share price fell by 10.9%. The MSCI Frontier Markets Net Total Return Index declined by 13.9% over the period. The manager says asset allocation, manager selection and discount movements […]
-
03 Mar 2015 1 min read
Advance Frontiers outperforms but let down by discount
Advance Frontier Markets Fund outperformed a falling benchmark (the MSCI Frontier Markets Index) over the six months ended 31 December 2014 – falling by 9.2% vs. -11.1%. The share price fell by 13.6% however as the fund’s discount shifted from 6.6% to 11.2%. The managers’ report says funds including Africa Emerging Markets Fund, Ashmore Middle […]
-
27 Nov 2014 1 min read
PXP Vietnam does well in its final year
VNF : PXP Vietnam does well in its final year PXP Vietnam has published its accounts for the year ended 30 September 2014, Over the period the fund’s net asset value rose by 25.9% while, by comparison, the VNI (the Vietnam Index) rose by 21.0%. Shareholders did even better as the discount narrowed, leading to a 42.7% […]
-
18 Sep 2014 1 min read
PXP Vietnam considering rollover into open ended fund
VNF : PXP Vietnam considering rollover into open ended fund The Board of PXP Vietnam Fund has announced that it is considering the merits of offering shareholders a rollover into an open ended fund managed by the same team (led by Kevin Snowball – pictured) The proposals are at an early stage and there is […]